申请人:XenoPort, Inc.
公开号:US08344028B2
公开(公告)日:2013-01-01
Gamma-amino-butyric acid derivatives that are GABAB receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed.
本发明涉及一种GABAB受体配体的Gamma-氨基丁酸衍生物,包括这种衍生物的制药组合物,以及使用这种衍生物和制药组合物治疗疾病的方法。